GoodRx vs Willow
GoodRx costs $150 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Willow
Best for: seeing what it charges before you answer any medical questions
Visit Willow →If you are choosing between GoodRx and Willow, the first difference is cost: GoodRx is $150 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.6.
GoodRx vs Willow price
GoodRx is the cheaper way in: $149 a month against $299 a month at Willow. That is $150 less each month (50% lower), or about $1,800 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $399 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Willow lists semaglutide.
On format, GoodRx prices brand-name pens, while Willow prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Willow does not publish where it ships.
Pricing
GoodRx
Willow
What each price covers
Willow's price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.
GoodRx does not say what its price includes.
Willow is silent on lab work and coaching.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Willow
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, GoodRx scores 6.9 and Willow 6.6 out of 10.
GoodRx is stronger on value (5.0 vs 3.0) and accessibility (10.0 vs 5.0).
Willow is stronger on user experience (8.0 vs 5.0), trust & safety (6.5 vs 6.0) and support (7.0 vs 5.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Willow
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Willow has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Willow |
|---|---|---|
| Starting Price | ✓$149/mo | $299/mo |
| Features | ✓6 features | 3 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Willow
Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.
Read our full Willow review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Willow
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Willow
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Willow is where we would start, above all for seeing what it charges before you answer any medical questions. GoodRx undercuts it by $150 a month, so if the monthly bill is what decides it, GoodRx is the pick. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Willow if…
You want seeing what it charges before you answer any medical questions and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →GoodRx vs Willow: FAQ
Close alternatives to GoodRx and Willow
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Willow vs Remedy Meds
- Willow vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.